ARQ: Future Upside Will Rely On Core Business As GAC Ramp Slows

Analysts have reduced their price target on Arq by $1.00 to $3.63, citing lower fair value assumptions, slightly higher discount rates, and tempered expectations for revenue growth and profit margins. They are reassessing the timing and profitability of the GAC ramp while focusing more on the core PAC business.

Analyst Commentary

Bullish Takeaways

Bullish analysts still see upside potential, even after lowering targets from $7.50 to $5 and from $8 to $6.50. This suggests they view the recent share price selloff as having reset expectations.
There is clear emphasis on profitable growth in the core PAC business. This segment is now being treated as the main driver of value while the GAC line works through its ramp up issues.
Some analysts frame the current period as an opportunity for better risk and reward, with lower valuation assumptions already incorporating recent execution challenges.
Analysts appear comfortable maintaining positive stock ratings despite reduced targets. This signals continued confidence in the underlying business model rather than a loss of faith in the company as a whole.

Bearish Takeaways

Analysts explicitly flag GAC execution challenges and leadership turnover as material overhangs. They expect these issues will take time for the company to work through and for investor confidence to rebuild.
The delay in reaching full utilization on the new GAC line from the original September 2025 timing to summer 2027 pushes out revenue and profit contributions. This directly feeds into lower fair value estimates.
Revised models now assume a shift in GAC under absorption cost drag from 2026 to 2027, which weighs on projected profitability across that extended period.
Analysts remove previously expected GAC revenue for 2026 from their assumptions, which narrows the near term growth profile and increases reliance on the PAC business to support future earnings power.

What's in the News

Arq issued earnings guidance for fiscal 2026, with expected revenue in a range of US$120 million to US$125 million (Key Developments).
The company decided to pause GAC production for a comprehensive engineering and process optimization review and does not expect any GAC production in fiscal 2026 (Key Developments).
Independent testing indicated the current thermal oxidizer can support about 15 million pounds of annual GAC production. Higher volumes would require additional modifications, prompting Arq to reassess required scale, capital needs, and return profiles before committing more investment (Key Developments).
Arq is temporarily idling its Corbin facility after moving away from using Corbin Wetcake for GAC products and is pursuing alternative uses such as asphalt emulsion blending (Key Developments).
The company recorded an impairment of long-lived assets of US$44,756,000 in the fourth quarter of 2025, linked to the GAC and Corbin decisions (Key Developments).

Valuation Changes

Fair Value: reduced from $4.63 to $3.63, reflecting lower modeled upside.
Discount Rate: increased slightly from 7.85% to 7.97%, implying a modestly higher required return.
Revenue Growth: reduced from 14.87% to 12.07%, reflecting more conservative dollar revenue assumptions.
Net Profit Margin: reduced from 8.28% to 6.82%, indicating lower expected dollar earnings relative to sales.
Future P/E: increased slightly from 16.91x to 17.38x, suggesting a marginally higher valuation multiple on projected earnings.

4 views

Key Takeaways

Expanding GAC production and regulatory-driven demand are enhancing revenue growth, margin expansion, and pricing power while strengthening Arq's market positioning.
Diversification into higher-margin RNG and a revitalized PAC business are improving earnings stability, reducing risk exposure, and supporting future capacity growth initiatives.
Delays in production ramp, regulatory uncertainty, market imbalances, tight liquidity, and commercialization risks threaten Arq's growth, margins, and financial stability.

Catalysts

About Arq

An environmental technology company, engages in the sale of consumable air, water, and soil treatment solutions based on activated carbon in the United States and Canada.What are the underlying business or industry changes driving this perspective?

The ramp-up of Arq's just-commissioned granular activated carbon (GAC) production line positions the company to rapidly increase high-margin sales into markets currently experiencing persistent supply shortages and 3%-5% annual growth, benefiting from regulatory drivers such as EPA water treatment mandates-supporting step-changes in revenue and margin expansion as capacity fills.
Growing regulatory pressure for clean water, specifically through anticipated implementation of PFAS regulations, is expected to drive GAC demand to 3-5x present levels by the end of the decade, with limited new supply entering the market, creating a secular tailwind for both top-line and pricing power over the coming years, directly impacting revenue growth and average selling price (ASP).
Rising demand for renewable natural gas (RNG) and its associated purification requirements, combined with Arq's outperformance in customer field trials and higher pricing/margin in this segment, is expected to further diversify the revenue base, reduce exposure to commoditized markets, and structurally enhance blended margins and earnings stability.
The turnaround and market diversification of the legacy PAC business-with reduced reliance on mercury applications (<40% of volumes), enhanced pricing power, and a now-consistently cash-generative profile-provides a stable financial foundation, both supporting future capital projects and underpinning resilience in free cash flow and EBITDA.
Strategic progress toward a second GAC line (with all permits in place, optimized design, and clear financing pathways via internal cash flow and debt) creates visible near-term optionality for doubling capacity and accelerating recurring revenue, while limiting shareholder dilution-setting up stronger economies of scale, margin leverage, and positive momentum in earnings per share.

Arq Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Arq's revenue will grow by 12.1% annually over the next 3 years.
Analysts assume that profit margins will increase from -43.7% today to 6.8% in 3 years time.
Analysts expect earnings to reach $11.6 million (and earnings per share of $0.23) by about April 2029, up from -$52.6 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $18.8 million in earnings, and the most bearish expecting $10.0 million.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 17.7x on those 2029 earnings, up from -1.8x today. This future PE is lower than the current PE for the US Chemicals industry at 29.7x.
Analysts expect the number of shares outstanding to grow by 1.51% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.97%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Arq's ability to execute and achieve full nameplate capacity for the new GAC line relies on successful ramp-up over the next 6 months, and any delays or operational setbacks could disrupt projected revenue growth and pressure margins in both the short and long term.
Regulatory risk remains significant, as the EPA's delay in full PFAS regulation implementation from 2029 to 2031 creates uncertainty on the timing and magnitude of demand acceleration, which could slow or shift anticipated earnings inflection points.
The company is highly dependent on sustained high pricing and a continued supply-demand imbalance in the granular activated carbon market; if competitor supply comes online sooner, or if demand growth underperforms expectations (particularly in key verticals like water treatment and RNG), Arq could see compressed net margins and weaker future revenues.
While management is confident in debt financing for Phase 2 expansion, the company's balance sheet shows only $7 million in unrestricted cash, and increased leverage or tighter credit markets could limit growth investment and increase financial risk, potentially impacting earnings stability.
Arq's ongoing R&D spend (with costs increasing 190% year-over-year in Q2) and dependence on successful commercialization of new applications (such as asphalt emulsion and rare earth products) introduces execution risk, where failure to deliver timely commercial results could prolong pressure on net income and cash flows.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $3.62 for Arq based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $5.0, and the most bearish reporting a price target of just $3.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $169.4 million, earnings will come to $11.6 million, and it would be trading on a PE ratio of 17.7x, assuming you use a discount rate of 8.0%.
Given the current share price of $2.23, the analyst price target of $3.62 is 38.5% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Arq?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

New GAC Line And RNG Expansion Will Fuel Demand